Merck & Co. Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	66,569	65,011	64,168	60,115	59,283	48,704
Revenue Growth	4.64%	1.31%	6.74%	1.40%	21.72%	17.31%
Cost of Revenue	16,043	14,815	14,698	15,915	17,206	13,466
Gross Profit	50,526	50,196	49,470	44,200	42,077	35,238
Selling, General & Admin	10,556	10,115	10,100	9,884	9,669	9,403
Research & Development	16,487	15,614	14,481	18,342	11,918	11,942
Operating Expenses	27,043	25,729	24,581	28,226	21,587	21,345
Operating Income	23,483	24,467	24,889	15,974	20,490	13,893
Interest Expense	-1,743	-1,357	-1,271	-1,146	-962	-806
Interest & Investment Income	235	343	415	365	157	36
Currency Exchange Gain (Loss)	-231	-323	-227	-370	-237	-297
Other Non Operating Income (Expenses)	141	203	290	419.5	681	256
EBT Excluding Unusual Items	21,885	23,333	24,096	15,243	20,129	13,082
Merger & Restructuring Charges	-16,527	-2,634	-4,344	-12,342	-666	-868
Gain (Loss) on Sale of Investments	590	368	14	340	-1,419	1,940
Asset Writedown	-	-	-	-779	-1,600	-275
Legal Settlements	-	-	-	-572.5	-	-
Other Unusual Items	-	-	170	-	-	-
Pretax Income	5,948	21,067	19,936	1,889	16,444	13,879
Income Tax Expense	2,779	2,804	2,803	1,512	1,918	1,521
Earnings From Continuing Operations	3,169	18,263	17,133	377	14,526	12,358
Earnings From Discontinued Operations	-	-	-	-	-	704
Net Income to Company	3,169	18,263	17,133	377	14,526	13,062
Minority Interest in Earnings	4	-9	-16	-12	-7	-13
Net Income	3,173	18,254	17,117	365	14,519	13,049
Net Income to Common	3,173	18,254	17,117	365	14,519	13,049
Net Income Growth	-80.66%	6.64%	4589.59%	-97.49%	11.27%	84.65%
Shares Outstanding (Basic)	2,480	2,502	2,532	2,537	2,532	2,530
Shares Outstanding (Diluted)	2,482	2,507	2,541	2,547	2,542	2,538
Shares Change	-1.92%	-1.34%	-0.24%	0.20%	0.16%	-0.12%
EPS (Basic)	1.28	7.30	6.76	0.14	5.73	5.16
EPS (Diluted)	1.27	7.28	6.74	0.14	5.71	5.14
EPS Growth	-80.37%	8.01%	4714.29%	-97.55%	11.15%	84.61%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	16,063	12,360	18,096	9,143	14,707	9,661
Free Cash Flow Per Share	6.47	4.93	7.12	3.59	5.79	3.81
Dividend Per Share	3.320	3.240	3.080	2.920	2.760	2.600
Dividend Growth	5.06%	5.20%	5.48%	5.80%	6.15%	6.56%
Gross Margin	75.90%	77.21%	77.09%	73.53%	70.98%	72.35%
Operating Margin	35.28%	37.64%	38.79%	26.57%	34.56%	28.52%
Profit Margin	4.77%	28.08%	26.67%	0.61%	24.49%	26.79%
Free Cash Flow Margin	24.13%	19.01%	28.20%	15.21%	24.81%	19.84%
EBITDA	28,871	29,105	29,134	19,706	24,279	17,016
EBITDA Margin	43.37%	44.77%	45.40%	32.78%	40.95%	34.94%
D&A For EBITDA	5,388	4,638	4,245	3,732	3,789	3,123
EBIT	23,483	24,467	24,889	15,974	20,490	13,893
EBIT Margin	35.28%	37.64%	38.79%	26.57%	34.56%	28.52%
Effective Tax Rate	46.72%	13.31%	14.06%	80.04%	11.66%	10.96%
Advertising Expenses	-	2,300	2,400	2,300	2,200	2,000

SEC Filings: 10-K · 10-Q